Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of acetyl-L-carnitine to reduce taxane- or platinum-induced sensory neuropathy
2005-000004-13Phase 3Completed
- Sponsor
- Leadiant Biosciences
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of acetyl-l-carnitine in peripheral neuropathy, sponsored by Leadiant Biosciences. Primary endpoint: Sensory neuropathy grade by NCI-CTC v3.0. Started Feb 2006; status: completed.
02
Drugs
acetyl-l-carnitine
03
Conditions
peripheral neuropathy
Beyond the preview
Go deeper on 2005-000004-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000004-13.